findmyKOL
Clinical trialNCT03976076TerminatedPhase 2Interventional

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

SponsorBio-Pharm Solutions Co., Ltd.Enrollment16Refractory Infantile Spasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Pusan National University Yangsan Hospital

    Pusan, Gyeongsangnam-do, South Korea

  • Kyungpook National University Chilgok Hospital (knuh)

    Daegu, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

United States
  • Arkansas Children'S Hospital

    Little Rock, Arkansas, United States

  • Children'S Hospital la

    Los Angeles, California, United States

  • Ucla - David Geffen School of Medicine

    Los Angeles, California, United States

  • Ucsf Epilepsy Center

    San Francisco, California, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • Nicklaus Children'S Hospital

    Miami, Florida, United States

  • Pediatric Neurology, Pa

    Winter Park, Florida, United States

  • Center for Rare Neurological Diseases

    Norcross, Georgia, United States

  • University of Louisville School of Medicine

    Louisville, Kentucky, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • the Children'S Hospital of Philadelphia (chop)

    Philadelphia, Pennsylvania, United States

  • Texas Children'S Hospital

    Houston, Texas, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

  • Multicare Institute for Research and Innovation

    Tacoma, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Apr 2020
Primary completion
10 Dec 2021
Completion
10 Dec 2021
Last update posted
22 Aug 2024
Registered enrollment
16
Registry id
NCT03976076

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.